Please select the option that best describes you:

Would you consider adjuvant chemotherapy in the management of retroperitoneal leiomyoscarcoma who did not respond to neoadjuvant doxorubicin/dacarbazine?  

And if so which?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Florida Cancer Specialists and Research Institute
How often do you use neoadjuvant treatment in thes...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more